Detalhe da pesquisa
1.
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.
N Engl J Med
; 387(5): 397-407, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921449
2.
A Monoclonal Antibody for Malaria Prevention.
N Engl J Med
; 385(9): 803-814, 2021 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379916
3.
Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression.
Lab Invest
; 97(1): 14-23, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27869798
4.
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.
Lancet Infect Dis
; 23(5): 578-588, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708738
5.
Combining Discordant Serum IgE and Skin Testing Improves Diagnostic and Therapeutic Accuracy for Hymenoptera Venom Hypersensitivity Immunotherapy.
J Allergy Clin Immunol Pract
; 10(3): 837-843.e3, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534718